Fig. 7From: Role of 18 fluorine-fluorodeoxyglucose positron emission tomography/computed tomography in assessment of neoadjuvant chemotherapy response in breast cancer patientsDistribution of the studied patients according to response to NAC determined by RECIST 1.1, PERCIST 1.0, and histopathologyBack to article page